BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35891431)

  • 1. Combination of E- and NS1-Derived DNA Vaccines: The Immune Response and Protection Elicited in Mice against DENV2.
    Pinto PBA; Barros TAC; Lima LM; Pacheco AR; Assis ML; Pereira BAS; Gonçalves AJS; Azevedo AS; Neves-Ferreira AGC; Costa SM; Alves AMB
    Viruses; 2022 Jun; 14(7):. PubMed ID: 35891431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T Cell Responses Induced by DNA Vaccines Based on the DENV2 E and NS1 Proteins in Mice: Importance in Protection and Immunodominant Epitope Identification.
    Pinto PBA; Assis ML; Vallochi AL; Pacheco AR; Lima LM; Quaresma KRL; Pereira BAS; Costa SM; Alves AMB
    Front Immunol; 2019; 10():1522. PubMed ID: 31333657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary evaluation of DNA vaccine candidates encoding dengue-2 prM/E and NS1: their immunity and protective efficacy in mice.
    Lu H; Xu XF; Gao N; Fan DY; Wang J; An J
    Mol Immunol; 2013 Jun; 54(2):109-14. PubMed ID: 23270684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA vaccines against dengue virus based on the ns1 gene: the influence of different signal sequences on the protein expression and its correlation to the immune response elicited in mice.
    Costa SM; Azevedo AS; Paes MV; Sarges FS; Freire MS; Alves AM
    Virology; 2007 Feb; 358(2):413-23. PubMed ID: 17020777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective immunity to DENV2 after immunization with a recombinant NS1 protein using a genetically detoxified heat-labile toxin as an adjuvant.
    Amorim JH; Diniz MO; Cariri FA; Rodrigues JF; Bizerra RS; Gonçalves AJ; de Barcelos Alves AM; de Souza Ferreira LC
    Vaccine; 2012 Jan; 30(5):837-45. PubMed ID: 22178517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The synergistic effect of combined immunization with a DNA vaccine and chimeric yellow fever/dengue virus leads to strong protection against dengue.
    Azevedo AS; Gonçalves AJ; Archer M; Freire MS; Galler R; Alves AM
    PLoS One; 2013; 8(3):e58357. PubMed ID: 23472186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A plasmid encoding parts of the dengue virus E and NS1 proteins induces an immune response in a mouse model.
    Mellado-Sánchez G; García-Machorro J; Sandoval-Montes C; Gutiérrez-Castañeda B; Rojo-Domínguez A; García-Cordero J; Santos-Argumedo L; Cedillo-Barrón L
    Arch Virol; 2010 Jun; 155(6):847-56. PubMed ID: 20390312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA priming E and NS1 constructs--homologous proteins boosting immunization strategy to improve immune response against dengue in mice.
    Mellado-Sánchez G; García-Cordero J; Luria-Pérez R; Lázaro-Olan L; Santos-Argumedo L; Gutiérrez-Castañeda B; Estrada-García I; Cedillo-Barrón L
    Viral Immunol; 2005; 18(4):709-21. PubMed ID: 16359237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a DNA vaccine candidate expressing prM-E-NS1 antigens of dengue virus serotype 1 with or without granulocyte-macrophage colony-stimulating factor (GM-CSF) in immunogenicity and protection.
    Zheng Q; Fan D; Gao N; Chen H; Wang J; Ming Y; Li J; An J
    Vaccine; 2011 Jan; 29(4):763-71. PubMed ID: 21095256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virus-like particle secretion and genotype-dependent immunogenicity of dengue virus serotype 2 DNA vaccine.
    Galula JU; Shen WF; Chuang ST; Chang GJ; Chao DY
    J Virol; 2014 Sep; 88(18):10813-30. PubMed ID: 25008922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the non-structural protein 1 from dengue virus to a dendritic cell population confers protective immunity to lethal virus challenge.
    Henriques HR; Rampazo EV; Gonçalves AJ; Vicentin EC; Amorim JH; Panatieri RH; Amorim KN; Yamamoto MM; Ferreira LC; Alves AM; Boscardin SB
    PLoS Negl Trop Dis; 2013; 7(7):e2330. PubMed ID: 23875054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against dengue type 2 virus induced in mice immunized with a DNA plasmid encoding the non-structural 1 (NS1) gene fused to the tissue plasminogen activator signal sequence.
    Costa SM; Paes MV; Barreto DF; Pinhão AT; Barth OM; Queiroz JL; Armôa GR; Freire MS; Alves AM
    Vaccine; 2006 Jan; 24(2):195-205. PubMed ID: 16122850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of a Recombinant Gamma-2 Herpesvirus Vaccine Vector against Dengue Virus in Rhesus Monkeys.
    Bischof GF; Magnani DM; Ricciardi M; Shin YC; Domingues A; Bailey VK; Gonzalez-Nieto L; Rakasz EG; Watkins DI; Desrosiers RC
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28592531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA vaccines against dengue virus type 2 based on truncate envelope protein or its domain III.
    Azevedo AS; Yamamura AM; Freire MS; Trindade GF; Bonaldo M; Galler R; Alves AM
    PLoS One; 2011; 6(7):e20528. PubMed ID: 21779317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inoculation of plasmid expressing the dengue 2 NS1 gene elicits immunity in mice].
    Yang CY; Chen Y; Yan HJ; Fang DY; Xue YH; Jiang LF
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Mar; 19(1):71-3. PubMed ID: 16201480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of protective efficacy and immune mechanisms of using a non-structural protein NS1 in DNA vaccine against dengue 2 virus in mice.
    Wu SF; Liao CL; Lin YL; Yeh CT; Chen LK; Huang YF; Chou HY; Huang JL; Shaio MF; Sytwu HK
    Vaccine; 2003 Sep; 21(25-26):3919-29. PubMed ID: 12922127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dimerization of Dengue Virus E Subunits Impacts Antibody Function and Domain Focus.
    Thomas A; Thiono DJ; Kudlacek ST; Forsberg J; Premkumar L; Tian S; Kuhlman B; de Silva AM; Metz SW
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32611757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cooperation between CD4+ T Cells and Humoral Immunity Is Critical for Protection against Dengue Using a DNA Vaccine Based on the NS1 Antigen.
    Gonçalves AJ; Oliveira ER; Costa SM; Paes MV; Silva JF; Azevedo AS; Mantuano-Barradas M; Nogueira AC; Almeida CJ; Alves AM
    PLoS Negl Trop Dis; 2015 Dec; 9(12):e0004277. PubMed ID: 26650916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NS1-based DNA vaccination confers mouse protective immunity against ZIKV challenge.
    Zhan Y; Pang Z; Du Y; Wang W; Yang Y; Wang W; Gao GF; Huang B; Deng Y; Tan W
    Infect Genet Evol; 2020 Nov; 85():104521. PubMed ID: 32882433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of a protective response in mice by the dengue virus NS3 protein using DNA vaccines.
    Costa SM; Yorio AP; Gonçalves AJ; Vidale MM; Costa EC; Mohana-Borges R; Motta MA; Freire MS; Alves AM
    PLoS One; 2011; 6(10):e25685. PubMed ID: 22031819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.